Catalyst Wire Dossier Catalyst Wire Dossier

Butantan Quadrivalent Influenza Vaccine (Split Virion, Inactivated)

quadrivalent split-virion inactivated influenza vaccine · Butantan Institute
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Butantan Quadrivalent Influenza Vaccine (Split Virion, Inactivated), covering 2025-09-19 to 2025-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety of Butantan Quadrivalent Influenza Vaccine (Split Virion, Inactivated) in Infants and Children . [Phase 3]

See pricing